{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T07:15:32Z","timestamp":1775978132646,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U01CA176726"],"award-info":[{"award-number":["U01CA176726"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U24CA210990"],"award-info":[{"award-number":["U24CA210990"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Preeclampsia has been inconsistently associated with altered later life risk of cancer. This study utilizes the Nurses\u2019 Health Study 2 (NHS2) to determine if the future risk of breast and non-breast cancers in women who experience preeclampsia is modified by carrying a protective variant of rs2016347, a functional insulin-like growth factor receptor-1 (<jats:italic>IGF1R)<\/jats:italic> single nucleotide polymorphism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective cohort study completed within the NHS2 evaluated participants enrolled in 1989 and followed them through 2015, with a study population of 86,751 after exclusions. Cox proportional hazards models both with and without the impact of rs2016347 genotype were used to assess the risk of invasive breast cancer, hormone receptor-positive (HR+) breast cancer, and non-breast cancers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Women with preeclampsia had no change in risk of all breast, HR+\u2009breast, or non-breast cancers when not considering genotype. However, women carrying at least one T allele of rs2016347 had a lower risk of HR+\u2009breast cancer, HR\u00a00.67, 95% CI: 0.47\u20130.97, <jats:italic>P<\/jats:italic>\u2009=\u20090.04, with interaction term <jats:italic>P<\/jats:italic>\u2009=\u20090.06. For non-breast cancers as a group, women carrying a T allele had an HR\u00a00.76, 95% CI: 0.53\u20131.08, <jats:italic>P<\/jats:italic>\u2009=\u20090.12, with interaction term <jats:italic>P<\/jats:italic>\u2009=\u20090.26.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This retrospective cohort study found that women with preeclampsia who carry a T allele of <jats:italic>IGF1R<\/jats:italic> rs2016347 had a reduced future risk of developing HR+\u2009breast cancer, and a reduced but not statistically significant decreased risk of non-breast cancers suggesting a possible role for the IGF-1 axis in the development of cancer in these women.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10549-022-06789-9","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T16:03:44Z","timestamp":1667577824000},"page":"149-159","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A common IGF1R gene variant predicts later life breast cancer risk in women with preeclampsia"],"prefix":"10.1007","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9945-5360","authenticated-orcid":false,"given":"Mark","family":"Powell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5682-615X","authenticated-orcid":false,"given":"Sophia","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2039-1964","authenticated-orcid":false,"given":"Erica","family":"Gunderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5479-4641","authenticated-orcid":false,"given":"Christopher","family":"Benz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,4]]},"reference":[{"issue":"12","key":"6789_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.39564","volume":"4","author":"E Boakye","year":"2021","unstructured":"Boakye E, Kwapong YA, Obisesan O et al (2021) Nativity-related disparities in preeclampsia and cardiovascular disease risk among a racially diverse cohort of US women. JAMA Netw Open 4(12):e2139564. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.39564","journal-title":"JAMA Netw Open"},{"issue":"1","key":"6789_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10549-022-06606-3","volume":"194","author":"Z Bigham","year":"2022","unstructured":"Bigham Z, Robles Y, Freund KM, Palmer JR, Bertrand KA (2022) Hypertensive diseases of pregnancy and risk of breast cancer in the Black women\u2019s health study. Breast Cancer Res Treat 194(1):127\u2013135. https:\/\/doi.org\/10.1007\/s10549-022-06606-3","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"6789_CR3","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s10552-017-0942-7","volume":"28","author":"MJ Powell","year":"2017","unstructured":"Powell MJ, Von Behren J, Neuhausen S, Reynolds P, Benz CC (2017) Functional IGF1R variant predicts breast cancer risk in women with preeclampsia in California teachers study. Cancer Causes Control 28(10):1027\u20131032. https:\/\/doi.org\/10.1007\/s10552-017-0942-7","journal-title":"Cancer Causes Control"},{"key":"6789_CR4","doi-asserted-by":"crossref","unstructured":"Powell M, Benz C, Ereman R, Prebil LA, Jamshidian F, Rose S. (2013) Abstract P3\u201307\u201303: insulin-like growth factor-1 receptor variant associated with decreased breast cancer risk in women with pregnancy-induced hypertension. Abstracts: thirty-sixth annual CTRC-AACR san antonio breast cancer symposium - Dec 10- 14, 2013; San Antonio, TX. Cancer Res 73(24suppl).","DOI":"10.1158\/0008-5472.SABCS13-P3-07-03"},{"issue":"7","key":"6789_CR5","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","volume":"124","author":"S Rana","year":"2019","unstructured":"Rana S, Lemoine E, Granger JP, Karumanchi SA (2019) Preeclampsia: pathophysiology, challenges, and perspectives [published correction appears in circ res. 2020 Jan 3,126(1):e8]. Circ Res 124(7):1094\u20131112. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313276","journal-title":"Circ Res"},{"issue":"1","key":"6789_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","volume":"170","author":"E Abalos","year":"2013","unstructured":"Abalos E, Cuesta C, Grosso AL, Chou D, Say L (2013) Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol 170(1):1\u20137. https:\/\/doi.org\/10.1016\/j.ejogrb.2013.05.005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"6789_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.116.003497","volume":"10","author":"P Wu","year":"2017","unstructured":"Wu P, Haththotuwa R, Kwok CS et al (2017) Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 10(2):e003497. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.116.003497","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"16","key":"6789_CR8","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1136\/heartjnl-2018-313453","volume":"105","author":"L Benschop","year":"2019","unstructured":"Benschop L, Duvekot JJ, Roeters van Lennep JE (2019) Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy. Heart 105(16):1273\u20131278. https:\/\/doi.org\/10.1136\/heartjnl-2018-313453","journal-title":"Heart"},{"issue":"9","key":"6789_CR9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/sj.bjc.6600581","volume":"87","author":"LJ Vatten","year":"2002","unstructured":"Vatten LJ, Romundstad PR, Trichopoulos D, Skjaerven R (2002) Preeclampsia in pregnancy and subsequent risk for breast cancer. Br J Cancer 87(9):971\u2013973. https:\/\/doi.org\/10.1038\/sj.bjc.6600581","journal-title":"Br J Cancer"},{"issue":"8","key":"6789_CR10","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3109\/0284186X.2012.750033","volume":"52","author":"JS Kim","year":"2013","unstructured":"Kim JS, Kang EJ, Woo OH et al (2013) The relationship between preeclampsia, pregnancy-induced hypertension and maternal risk of breast cancer: a meta-analysis. Acta Oncol 52(8):1643\u20131648. https:\/\/doi.org\/10.3109\/0284186X.2012.750033","journal-title":"Acta Oncol"},{"issue":"1","key":"6789_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/bjc.2012.195","volume":"107","author":"S Opdahl","year":"2012","unstructured":"Opdahl S, Romundstad PR, Alsaker MD, Vatten LJ (2012) Hypertensive diseases in pregnancy and breast cancer risk. Br J Cancer 107(1):176\u2013182. https:\/\/doi.org\/10.1038\/bjc.2012.195","journal-title":"Br J Cancer"},{"issue":"9","key":"6789_CR12","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1093\/aje\/kwk105","volume":"165","author":"MB Terry","year":"2007","unstructured":"Terry MB, Perrin M, Salafia CM et al (2007) Preeclampsia, pregnancy-related hypertension, and breast cancer risk. Am J Epidemiol 165(9):1007\u20131014. https:\/\/doi.org\/10.1093\/aje\/kwk105","journal-title":"Am J Epidemiol"},{"issue":"18","key":"6789_CR13","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1080\/14767058.2017.1342806","volume":"31","author":"M Sun","year":"2018","unstructured":"Sun M, Fan Y, Hou Y, Fan Y (2018) Preeclampsia and maternal risk of breast cancer: a meta-analysis of cohort studies. J Matern Fetal Neonatal Med 31(18):2484\u20132491. https:\/\/doi.org\/10.1080\/14767058.2017.1342806","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"6789_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preghy.2011.08.116","volume":"2","author":"S Bhattacharya","year":"2012","unstructured":"Bhattacharya S, Prescott GJ, Iversen L, Campbell DM, Smith WC, Hannaford PC (2012) Hypertensive disorders of pregnancy and future health and mortality: a record linkage study. Pregnancy Hypertens 2(1):1\u20137. https:\/\/doi.org\/10.1016\/j.preghy.2011.08.116","journal-title":"Pregnancy Hypertens"},{"issue":"9","key":"6789_CR15","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1097\/GME.0000000000001806","volume":"28","author":"F Wang","year":"2021","unstructured":"Wang F, Zhang W, Cheng W, Huo N, Zhang S (2021) Preeclampsia and cancer risk in women in later life: a systematic review and meta-analysis of cohort studies. Menopause 28(9):1070\u20131078. https:\/\/doi.org\/10.1097\/GME.0000000000001806","journal-title":"Menopause"},{"issue":"6","key":"6789_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.14486","volume":"4","author":"C Serrand","year":"2021","unstructured":"Serrand C, Mura T, Fabbro-Peray P et al (2021) Assessment of all-cause cancer incidence among individuals with preeclampsia or eclampsia during first pregnancy. JAMA Netw Open 4(6):e2114486. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.14486","journal-title":"JAMA Netw Open"},{"issue":"1","key":"6789_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/ijc.30065","volume":"139","author":"I Behrens","year":"2016","unstructured":"Behrens I, Basit S, Jensen A et al (2016) Hypertensive disorders of pregnancy and subsequent risk of solid cancer\u2013a nationwide cohort study. Int J Cancer 139(1):58\u201364. https:\/\/doi.org\/10.1002\/ijc.30065","journal-title":"Int J Cancer"},{"issue":"12","key":"6789_CR18","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1016\/j.mayocp.2020.03.037","volume":"95","author":"MJ Powell","year":"2020","unstructured":"Powell MJ, Dufault SM, Gunderson EP, Benz CC (2020) Cancer and cardiovascular risk in women with hypertensive disorders of pregnancy carrying a common IGF1R variant. Mayo Clin Proc 95(12):2684\u20132696. https:\/\/doi.org\/10.1016\/j.mayocp.2020.03.037","journal-title":"Mayo Clin Proc"},{"key":"6789_CR19","first-page":"147","volume-title":"From Preconception to Postpartum","author":"D Kappou","year":"2012","unstructured":"Kappou D, Vrachnis N, Sifakis S (2012) Recent insights into the role of the insulin-like growth factor axis in preeclampsia. In: Sifakis S (ed) From Preconception to Postpartum. InTech, pp 147\u2013160 (ISBN: 978- 953-51-0353-0)"},{"issue":"2","key":"6789_CR20","first-page":"192","volume":"27","author":"HY Peng","year":"2011","unstructured":"Peng HY, Xue M, Xia AB (2011) Study on changes of IGF-I and leptin levels in serum and placental tissue of preeclampsia patients and their associativity. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 27(2):192\u2013194","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"issue":"4","key":"6789_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3109\/08977194.2013.802692","volume":"31","author":"A Olmos","year":"2013","unstructured":"Olmos A, D\u00edaz L, Avila E et al (2013) Associations between insulin-like growth factor I, vascular endothelial growth factor and its soluble receptor 1 in umbilical serum and endothelial cells obtained from normotensive and preeclamptic pregnancies. Growth Factors 31(4):123\u2013129. https:\/\/doi.org\/10.3109\/08977194.2013.802692","journal-title":"Growth Factors"},{"issue":"1","key":"6789_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10517-014-2502-4","volume":"157","author":"EA Dubova","year":"2014","unstructured":"Dubova EA, Pavlov KA, Lyapin VM, Kulikova GV, Shchyogolev AI, Sukhikh GT (2014) Expression of insulin-like growth factors in the placenta in preeclampsia. Bull Exp Biol Med 157(1):103\u2013107. https:\/\/doi.org\/10.1007\/s10517-014-2502-4","journal-title":"Bull Exp Biol Med"},{"issue":"1","key":"6789_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/1573402113666170126101914","volume":"13","author":"S Kharb","year":"2017","unstructured":"Kharb S, Nanda S (2017) Patterns of biomarkers in cord blood during pregnancy and preeclampsia. Curr Hypertens Rev 13(1):57\u201364. https:\/\/doi.org\/10.2174\/1573402113666170126101914","journal-title":"Curr Hypertens Rev"},{"issue":"3","key":"6789_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/s0009-9120(03)00008-0","volume":"36","author":"K Altinkaynak","year":"2003","unstructured":"Altinkaynak K, H\u00fc AH, Bakan E, Kumtepe Y (2003) Serum IGF-I and IGFBP-3 in healthy pregnancies and patients with preeclampsia. Clin Biochem 36(3):221\u2013223. https:\/\/doi.org\/10.1016\/s0009-9120(03)00008-0","journal-title":"Clin Biochem"},{"key":"6789_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.preghy.2017.07.148","volume":"10","author":"S Liao","year":"2017","unstructured":"Liao S, Vickers MH, Taylor RS et al (2017) Maternal serum IGF-1, IGFBP-1 and 3, and placental growth hormone at 20weeks\u2019 gestation in pregnancies complicated by preeclampsia. Pregnancy Hypertens 10:149\u2013154. https:\/\/doi.org\/10.1016\/j.preghy.2017.07.148","journal-title":"Pregnancy Hypertens"},{"issue":"1","key":"6789_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12282-020-01182-0","volume":"28","author":"X Wu","year":"2021","unstructured":"Wu X, Zhang X, Hao Y, Li J (2021) Obesity-related protein biomarkers for predicting breast cancer risk: an overview of systematic reviews. Breast Cancer 28(1):25\u201339. https:\/\/doi.org\/10.1007\/s12282-020-01182-0","journal-title":"Breast Cancer"},{"key":"6789_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-015-0291-7","volume":"14","author":"PF Christopoulos","year":"2015","unstructured":"Christopoulos PF, Msaouel P, Koutsilieris M (2015) The role of the insulin-like growth factor-1 system in breast cancer. Mol Cancer 14:43. https:\/\/doi.org\/10.1186\/s12943-015-0291-7","journal-title":"Mol Cancer"},{"issue":"6","key":"6789_CR28","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S1470-2045(10)70095-4","volume":"11","author":"TJ Key","year":"2010","unstructured":"Key TJ, Appleby PN, Reeves GK, Roddam AW, Endogenous Hormones and Breast Cancer Collaborative Group (2010) Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11(6):530\u2013542. https:\/\/doi.org\/10.1016\/S1470-2045(10)70095-4","journal-title":"Lancet Oncol"},{"issue":"1","key":"6789_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10549-010-1313-1","volume":"128","author":"RM Tamimi","year":"2011","unstructured":"Tamimi RM, Colditz GA, Wang Y et al (2011) Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer. Breast Cancer Res Treat 128(1):243\u2013250. https:\/\/doi.org\/10.1007\/s10549-010-1313-1","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"6789_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13058-020-01352-0","volume":"22","author":"KR Monson","year":"2020","unstructured":"Monson KR, Goldberg M, Wu HC, Santella RM, Chung WK, Terry MB (2020) Circulating growth factor concentrations and breast cancer risk: a nested case-control study of IGF-1, IGFBP-3, and breast cancer in a family-based cohort. Breast Cancer Res 22(1):109. https:\/\/doi.org\/10.1186\/s13058-020-01352-0","journal-title":"Breast Cancer Res"},{"issue":"5","key":"6789_CR31","first-page":"1641","volume":"30","author":"RE Friedrich","year":"2010","unstructured":"Friedrich RE, Hagel C, Bartel-Friedrich S (2010) Insulin-like growth factor-1 receptor (IGF-1R) in primary and metastatic undifferentiated carcinoma of the head and neck: a possible target of immunotherapy. Anticancer Res 30(5):1641\u20131643","journal-title":"Anticancer Res"},{"issue":"1","key":"6789_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3747\/co.23.2669","volume":"23","author":"S Fu","year":"2016","unstructured":"Fu S, Tang H, Liao Y et al (2016) Expression and clinical significance of insulin-like growth factor 1 in lung cancer tissues and perioperative circulation from patients with non-small-cell lung cancer. Curr Oncol 23(1):12\u201319. https:\/\/doi.org\/10.3747\/co.23.2669","journal-title":"Curr Oncol"},{"issue":"7","key":"6789_CR33","first-page":"2541","volume":"31","author":"I Shiratsuchi","year":"2011","unstructured":"Shiratsuchi I, Akagi Y, Kawahara A et al (2011) Expression of IGF-1 and IGF-1R and their relation to clinicopathological factors in colorectal cancer. Anticancer Res 31(7):2541\u20132545","journal-title":"Anticancer Res"},{"issue":"3","key":"6789_CR34","first-page":"9","volume":"23","author":"F Nurwidya","year":"2016","unstructured":"Nurwidya F, Andarini S, Takahashi F, Syahruddin E, Takahashi K (2016) Implications of insulin-like growth factor 1 receptor activation in lung cancer. Malays J Med Sci 23(3):9\u201321","journal-title":"Malays J Med Sci"},{"issue":"12","key":"6789_CR35","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/carcin\/bgy112","volume":"39","author":"TU Ahearn","year":"2018","unstructured":"Ahearn TU, Peisch S, Pettersson A et al (2018) Expression of IGF\/insulin receptor in prostate cancer tissue and progression to lethal disease. Carcinogenesis 39(12):1431\u20131437. https:\/\/doi.org\/10.1093\/carcin\/bgy112","journal-title":"Carcinogenesis"},{"key":"6789_CR36","doi-asserted-by":"publisher","first-page":"6018432","DOI":"10.1155\/2019\/6018432","volume":"2019","author":"MJ Powell","year":"2019","unstructured":"Powell MJ, Dufault SM, Henry JE, Allison AC, Cora R, Benz CC (2019) Pregnancy hypertension and a commonly Inherited IGF1R variant (rs2016347) reduce breast cancer risk by enhancing mammary gland involution. J Oncol 2019:6018432. https:\/\/doi.org\/10.1155\/2019\/6018432","journal-title":"J Oncol"},{"issue":"7","key":"6789_CR37","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s10552-014-0386-2","volume":"25","author":"LA Prebil","year":"2014","unstructured":"Prebil LA, Ereman RR, Powell MJ et al (2014) First pregnancy events and future breast density: modification by age at first pregnancy and specific VEGF and IGF1R gene variants. Cancer Causes Control 25(7):859\u2013868. https:\/\/doi.org\/10.1007\/s10552-014-0386-2","journal-title":"Cancer Causes Control"},{"key":"6789_CR38","unstructured":"GTEx portal. Variant page. (2022) The Broad Institute of MIT and Harvard. https:\/\/www.gtexportal.org\/home\/snp\/rs2016347. Last accessed April 10, 2022"},{"issue":"1","key":"6789_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13058-015-0663-3","volume":"18","author":"S de Groot","year":"2016","unstructured":"de Groot S, Charehbili A, van Laarhoven HW et al (2016) Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010\u201301). Breast Cancer Res 18(1):3. https:\/\/doi.org\/10.1186\/s13058-015-0663-3","journal-title":"Breast Cancer Res"},{"issue":"1","key":"6789_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/tpj.2013.8","volume":"14","author":"T Winder","year":"2014","unstructured":"Winder T, Giamas G, Wilson PM et al (2014) Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen. Pharmacogenomics J 14(1):28\u201334. https:\/\/doi.org\/10.1038\/tpj.2013.8","journal-title":"Pharmacogenomics J"},{"issue":"9","key":"6789_CR41","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2105\/AJPH.2016.303338","volume":"106","author":"Y Bao","year":"2016","unstructured":"Bao Y, Bertoia ML, Lenart EB et al (2016) Origin, methods, and evolution of the three nurses\u2019 health studies. Am J Pub Health 106(9):1573\u20131581. https:\/\/doi.org\/10.2105\/AJPH.2016.303338","journal-title":"Am J Pub Health"},{"issue":"9","key":"6789_CR42","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.2105\/AJPH.2016.303343","volume":"106","author":"GA Colditz","year":"2016","unstructured":"Colditz GA, Philpott SE, Hankinson SE (2016) The impact of the nurses\u2019 health study on population health: prevention, translation, and control. Am J Pub Health 106(9):1540\u20131545. https:\/\/doi.org\/10.2105\/AJPH.2016.303343","journal-title":"Am J Pub Health"},{"issue":"9","key":"6789_CR43","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.2105\/AJPH.2016.303350","volume":"106","author":"JE Chavarro","year":"2016","unstructured":"Chavarro JE, Rich-Edwards JW, Gaskins AJ et al (2016) Contributions of the nurses\u2019 health studies to reproductive health research. Am J Public Health 106(9):1669\u20131676. https:\/\/doi.org\/10.2105\/AJPH.2016.303350","journal-title":"Am J Public Health"},{"issue":"3","key":"6789_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173997","volume":"12","author":"S Lindstr\u00f6m","year":"2017","unstructured":"Lindstr\u00f6m S, Loomis S, Turman C et al (2017) A comprehensive survey of genetic variation in 20,691 subjects from four large cohorts. PLoS ONE 12(3):e0173997. https:\/\/doi.org\/10.1371\/journal.pone.0173997","journal-title":"PLoS ONE"},{"issue":"5","key":"6789_CR45","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/humrep\/deac059","volume":"37","author":"MJ Powell","year":"2022","unstructured":"Powell MJ, Fuller S, Gunderson EP, Benz CC (2022) Reduced cardiovascular risks in women with endometriosis or polycystic ovary syndrome carrying a common functional IGF1R variant. Hum Reprod 37(5):1083\u20131094. https:\/\/doi.org\/10.1093\/humrep\/deac059","journal-title":"Hum Reprod"},{"issue":"3","key":"6789_CR46","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1080\/00949655.2017.1397151","volume":"88","author":"PC Austin","year":"2018","unstructured":"Austin PC (2018) Statistical power to detect violation of the proportional hazards assumption when using the cox regression model. J Stat Comput Simul 88(3):533\u2013552. https:\/\/doi.org\/10.1080\/00949655.2017.1397151","journal-title":"J Stat Comput Simul"},{"key":"6789_CR47","unstructured":"R Core Team (2022). R: A language and environment for statistical computing. Foundation for Statistical Computing, Vienna, Austria. URL: http:\/\/www.r-project.org\/index.html"},{"key":"6789_CR48","unstructured":"R Project for Statistical Computing. (2020) The R foundation. A Package for Survival Analysis in S. Version 2.38. https:\/\/www.R-project.org\/. Accessed June 6, 2020"},{"key":"6789_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling survival data: extending the cox model","author":"T Therneau","year":"2000","unstructured":"Therneau T, Grambsch P (2000) Modeling survival data: extending the cox model. Springer-Verlag, New York, New York, NY"},{"key":"6789_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"Ggplot2: elegant graphics for data analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H (2016) Ggplot2: elegant graphics for data analysis. Springer International Publishing, New York, NY"},{"key":"6789_CR51","doi-asserted-by":"publisher","first-page":"570","DOI":"10.32614\/RJ-2021-053","volume":"13","author":"D Sjoberg","year":"2021","unstructured":"Sjoberg D, Whiting K, Curry M, Lavery J, Larmarange J (2021) Reproducible summary tables with the gtsummary package. The R J 13:570\u2013580. https:\/\/doi.org\/10.32614\/RJ-2021-053","journal-title":"The R J"},{"issue":"7","key":"6789_CR52","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2174\/156800908786241104","volume":"8","author":"M Lanzino","year":"2008","unstructured":"Lanzino M, Morelli C, Garofalo C et al (2008) Interaction between estrogen receptor alpha and insulin\/IGF signaling in breast cancer. Curr Cancer Drug Targ 8(7):597\u2013610. https:\/\/doi.org\/10.2174\/156800908786241104","journal-title":"Curr Cancer Drug Targ"},{"key":"6789_CR53","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.bbcan.2013.10.005","volume":"2","author":"Y Hawsawi","year":"1836","unstructured":"Hawsawi Y, El-Gendy R, Twelves C, Speirs V, Beattie J (1836) (2013) Insulin-like growth factor\u2014oestradiol crosstalk and mammary gland tumourigenesis. Biochim Biophys Acta 2:345\u2013353. https:\/\/doi.org\/10.1016\/j.bbcan.2013.10.005","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"6789_CR54","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s12282-018-0922-0","volume":"26","author":"M Iida","year":"2019","unstructured":"Iida M, Tsuboi K, Niwa T, Ishida T, Hayashi SI (2019) Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer. Breast Cancer 26(3):272\u2013281. https:\/\/doi.org\/10.1007\/s12282-018-0922-0","journal-title":"Breast Cancer"},{"issue":"4","key":"6789_CR55","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.molonc.2015.10.010","volume":"10","author":"CC Engels","year":"2016","unstructured":"Engels CC, de Glas NA, Sajet A et al (2016) The influence of insulin-like growth factor-1-receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: a Dutch team substudy analysis. Mol Oncol 10(4):509\u2013516. https:\/\/doi.org\/10.1016\/j.molonc.2015.10.010","journal-title":"Mol Oncol"},{"issue":"3","key":"6789_CR56","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/PAI.0b013e3181ffc58c","volume":"19","author":"R Bhargava","year":"2011","unstructured":"Bhargava R, Beriwal S, McManus K, Dabbs DJ (2011) Insulin-like growth factor receptor-1 (IGF-1R) expression in normal breast, proliferative breast lesions, and breast carcinoma. Appl Immunohistochem Mol Morphol 19(3):218\u2013225. https:\/\/doi.org\/10.1097\/PAI.0b013e3181ffc58c","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"4","key":"6789_CR57","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7326\/M17-2740","volume":"169","author":"JJ Stuart","year":"2018","unstructured":"Stuart JJ, Tanz LJ, Missmer SA et al (2018) Hypertensive disorders of pregnancy and maternal cardiovascular disease risk factor development: an observational cohort study. Ann Intern Med 169(4):224\u2013232. https:\/\/doi.org\/10.7326\/M17-2740","journal-title":"Ann Intern Med"},{"issue":"1","key":"6789_CR58","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1089\/jwh.2012.3740","volume":"22","author":"JJ Stuart","year":"2013","unstructured":"Stuart JJ, Bairey Merz CN, Berga SL et al (2013) Maternal recall of hypertensive disorders in pregnancy: a systematic review. J Womens Health (Larchmt) 22(1):37\u201347. https:\/\/doi.org\/10.1089\/jwh.2012.3740","journal-title":"J Womens Health (Larchmt)"},{"issue":"9","key":"6789_CR59","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1089\/jwh.2014.4953","volume":"24","author":"EB Carter","year":"2015","unstructured":"Carter EB, Stuart JJ, Farland LV et al (2015) Pregnancy complications as markers for subsequent maternal cardiovascular disease: validation of a maternal recall questionnaire. J Womens Health (Larchmt) 24(9):702\u2013712. https:\/\/doi.org\/10.1089\/jwh.2014.4953","journal-title":"J Womens Health (Larchmt)"},{"key":"6789_CR60","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l2381","volume":"366","author":"GJ Burton","year":"2019","unstructured":"Burton GJ, Redman CW, Roberts JM, Moffett A (2019) Pre-eclampsia: pathophysiology and clinical implications. BMJ 366:l2381. https:\/\/doi.org\/10.1136\/bmj.l2381","journal-title":"BMJ"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06789-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-022-06789-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06789-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T05:24:41Z","timestamp":1672982681000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-022-06789-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,4]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["6789"],"URL":"https:\/\/doi.org\/10.1007\/s10549-022-06789-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,4]]},"assertion":[{"value":"28 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known potential financial conflicts of interest or personal relationships that could have appeared to influence the research or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The NHS2 study protocol was approved by the Institutional Review Board (IRB) of the Brigham and Women's Hospital, and the IRB allowed participants\u2019 completion of questionnaires as implied consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}